Interleukin-1 signaling in mouse astrocytes involves Akt: A study with interleukin-4 and interleukin-10

European Cytokine Network

Volumn 11, Issue 3, 2000, Pages 427-434

  Pousset, F ^a   Dantzer, R ^a   Kelly, K W ^a   Parnet, P ^a  

^a INSERM   (France)

Author keywords

Akt; Astrocyte; IL 1; IL 10; IL 4; NF B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AKT; UNCLASSIFIED DRUG;

ANIMAL CELL; ASTROCYTE; CONTROLLED STUDY; IMMUNOREGULATION; INFLAMMATION; MOUSE; NEWBORN; NONHUMAN; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BRAIN; CELLS, CULTURED; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-4; MICE; NF-KAPPA B; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; RECEPTORS, INTERLEUKIN-1; RETROVIRIDAE PROTEINS, ONCOGENIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0034457369     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist
2. Interleukin-1, nitric oxide and reactive astrocytes
3. Reactive astrocytes: Cellular and molecular cues to biological function
4. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily
5. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types
6. Interleukin-1 type II receptor: A decoy target for IL-1 that is regulated by IL-4: A novel regulatory pathway for interleukin-1
7. Molecular cloning and characterization of a second subunit of the interleukin-1 receptor complex
8. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor deficient mice
9. Function and activation of NFκB in the immune system
10. Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein
11. Tumor necrosis factor-alpha-dependent activation of a Rel A homodimer in astrocytes. Increased phosphorylation of Rel A and MAD3 precede activation of Rel A
12. Interleukin-1β uses common and distinct signalling pathways for induction of the interleukin-6 and tumor necrosis factor-α genes in human astrocytoma cell line U373
13. Phosphatidylinositol 3-kinase in IL-1 signaling
14. Phosphatidylinositol 3-kinase is recruited to a specific site in the activated IL-1 receptor I
15. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate
16. A retroviral oncogene, akt, encoding a serine threonine kinase containing an SH2-like region
17. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
18. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB
19. Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3
20. NFκB is a target of Akt in anti-apoptotic PDGF signalling
21. Activation of phosphatidylinositol 3-kinase in response to IL-1 leads to phosphorylation and activation of the NFκB p65/RelA subunit
22. Molecular regulation of cytokine gene expression during the immune response
23. The CDK inhibitor, p27Kip1, is required for IL-4 regulation of astrocyte proliferation
24. Modulation of proliferation and antigen expression of a cloned human glioblastoma by interleukin-4 alone and in combination with tumor necrosis factor-α and/or interferon-γ
25. Effects of IL-10 and IL-4 on LPS-induced transcription factors (AP-1, NF-IL-6 and NFκB) which are involved in IL-6 regulation
26. In vivo suppression of NFκB and preservation of I kappa B alpha by interleukin-10 and interleukin-13
27. MAP kinase pathways as a route for regulatory mechanisms of IL-10 and IL-4 which inhibit COX-2 expression in human monocytes
28. Neuronal regulation of astroglial morphology and proliferation in vitro
29. Interleukin-4 and interleukin-10 regulate IL-1β induced mouse primary astrocyte activation: A comparative study
30. Interleukin-10 inhibits nuclear factor kappa B (NFκB) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms
31. Effect of serotonin on cytokine mRNA expression in rat hippocampal astrocytes
32. Expression of type I and type II interleukin-1 receptor in mouse brain
33. Rapid detection of octamer binding proteins with mini-extracts prepared from a small number of cells
34. Interleukin-1 activates transcription factor NFκB in glial cells
35. Constitutive nuclear NFκB in cells of the monocyte lineage
36. Two high-affinity interleukin-1 receptors represent separate gene products
37. Human/mouse interleukin-1 receptor/receptor accessory protein interactions in IL-1β induced NFκB activation
38. Requirement for phosphatidylinositol 3′-kinase to protect hemopoietic progenitors against apopotosis depends upon the extracellular survival factor
39. The differential production of three forms of IL-1 receptor antagonist by human neutrophils and monocytes
40. The glucose oxydase-DAB-nickel method in peroxydase histochemistry of the nervous system
41. Demonstration of the presence of an interleukin-1 receptor on the surface of murine astrocytes and its regulation by cytokines and Theiler's virus
42. Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NFκB-like nuclear protein
43. Mechanism for biphasic rel A NF kappa B1 nuclear translocation in tumor necrosis factor alpha stimulated hepatocytes
44. Transient NFκB activation stimulated by IL-1β may be partly dependent on proteasome activity, but not phosphorylation and ubiquitination of the IκBα molecule, in C6 glioma cells. Regulation of NF-κB linked to chemokin production
45. IL-1 mediated febrile responses in mice and IL-1β activation of NFκB in mouse primary astrocytes, involves the interleukin-1 receptor accessory protein
46. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC
47. Wortmanin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase
48. NFκB activation by tumor necrosis factor requires the Akt serine-threonine kinase
49. Induction of vascular cell adhesion molecule-1 expression by IL-4 in human aortic smooth muscle cells is not associated with increased nuclear factor kappa B levels
50. IL-10 down-regulates human microglial IL-8 by inhibition of NFκB activation
51. IL-4 and IL-13 enhance the effect of IL-1β on production of IL-1 receptor antagonist by human primary hepatocytes and hepatoma HepG2 cells: Differential effect on C-reactive protein production
52. IL-10 stimulation of PI3-kinase and p70 S6 kinase is required for the proliferative but not the anti-inflammatory effects of the cytokine
53. Role of Akt and c-Jun N-terminal kinase 2 in apoptosis induced by interleukin-4 deprivation
54. Inhibition of the phosphatidylinositol 3-kinase/p70(S6)-kinase pathway induces B16 melanoma cell differentiation